Dr Julia Brotherton

Senior Lecturer
Paediatrics & Child Health, Children's Hospital, Westmead

C29 - Children's Hospital Westmead
The University of Sydney
NSW 2006 Australia

T: 9845 0651
F: 9845 3095
E:

Publications

2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

2014

   
  • Brotherton, J., Liu, B., Donovan, B., Kaldor, J., Saville, M. (2014), Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey. Vaccine. 32(5), 592-597. [Abstract]

2013

   
  • Brotherton, J., Murray, S., Hall, M., Andrewartha, L., Banks, C., Meijer, D., Pitcher, H., Scully, M., Molchanoff, L. (2013), Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. The Medical Journal of Australia. 199(9), 614-617. [Abstract]

2012

   
  • Tabrizi, S., Brotherton, J., Kaldor, J., Skinner, S., Cummins, E., Liu, B., Bateson, D., McNamee, K., Garefalakis, M., Garland, S. (2012), Fall in human papillomavirus prevalence following a national vaccination program. Journal of Infectious Diseases. 206(11), 1645-1651. [Abstract]
  • Georgousakis, M., Jayasinghe, S., Brotherton, J., Gilroy, N., Chiu, C., Macartney, K. (2012), Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study. The Lancet Infectious Diseases. 12(8), 627-634. [Abstract]
  • Brotherton, J., Tabrizi, S., Garland, S. (2012), Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance. Future Microbiology. 7(2), 193-199. [Abstract]

2011

   
  • Garland, S., Skinner, S., Brotherton, J. (2011), Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Preventive Medicine. 53(Suppl 1), S29-S35. [Abstract]
  • Brotherton, J., Gertig, D. (2011), Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact. Expert Review of Anti-Infective Therapy. 9(8), 627-639. [Abstract]
  • Jin, F., Stein, A., Conway, E., Regan, D., Law, M., Brotherton, J., Hocking, J., Grulich, A. (2011), Trends in anal cancer in Australia, 1982-2005. Vaccine. 29(12), 2322-2327. [Abstract]
  • Liu, B., Brotherton, J., Shellard, D., Donovan, B., Saville, M., Kaldor, J. (2011), Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods. BMC Medical Research Methodology. 11, 159. [Abstract]
  • Garland, S., Brotherton, J., Condon, J., McIntyre, P., Stevens, M., Smith, D., Tabrizi, S. (2011), Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Medicine. 9(104), 1-13. [Abstract]

2010

   
  • Chiu, C., Dey, A., Wang, H., Menzies, R., Deeks, S., Mahajan, D., Macartney, K., Brotherton, J., Jardine, A., Quinn, H., Jelfs, J., Booy, R., Lawrence, G., Jayasinghe, S., Roberts-Witteveen, A., Senanayake, S., Wood, N., McIntyre, P. (2010), Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence. 34 Supp, S1-167. [Abstract]
  • Cooper Robbins, S., Bernard, D., McCaffery, K., Brotherton, J., Skinner, S. (2010), "I just signed": Factors influencing decision-making for school-based HPV vaccination of adolescent girls. Health Psychology. 29(6), 618-625. [Abstract]
  • Brotherton, J., Leask, J., Jackson, C., McCaffery, K., Trevena, L. (2010), National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program. Sexual Health. 7(3), 291-298. [Abstract]
  • Cooper Robbins, S., Bernard, D., McCaffery, K., Brotherton, J., Garland, S., Skinner, S. (2010), "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination. Vaccine. 28(19), 3398-3408. [Abstract]
  • Quinn, H., McIntyre, P., Backhouse, J., Gidding, H., Brotherton, J., Gilbert, G. (2010), The utility of seroepidemiology for tracking trends in pertussis infection. Epidemiology and infection. 138(3), 426-33. [Abstract]
  • Novakovic, D., Cheng, A., Cope, D., Brotherton, J. (2010), Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study. Sexual Health. 7(3), 253-261. [Abstract]

2009

   
  • Leask, J., Jackson, C., Trevena, L., McCaffery, K., Brotherton, J. (2009), Implementation of the Australian HPV vaccination program for adult women: Qualitative key informant interviews. Vaccine. 27(40), 5505-12. [Abstract]
  • Brotherton, J., Heywood, A., Heley, S. (2009), The incidence of genital warts in Australian women prior to the national vaccination program. Sexual Health. 6(3), 178-184. [Abstract]
  • McIntyre, P., Brotherton, J., Burgess, M., Kemp, A. (2009), More data from Australia on sensitivity to HPV vaccine. BMJ (Clinical research ed.). , b26. [Abstract]
  • Agorastos, T., Chatzigeorgiou, K., Brotherton, J., Garland, S. (2009), Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far. Vaccine. 27(52), 7270-7281. [Abstract]

2008

   
  • Brotherton, J., Deeks, S., Campbell-Lloyd, S., Misrachi, A., Passaris, I., Peterson, K., Pitcher, H., Scully, M., Watson, M., Webby, R. (2008), Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Communicable diseases intelligence. 32(4), 457-461. [Abstract]
  • Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008), The predicted impact of vaccination on human papillomavirus infections in Australia. International journal of cancer. Journal international du cancer. 123(8), 1854-63. [Abstract]
  • Brotherton, J., Gold, M., Kemp, A., McIntyre, P., Burgess, M., Campbell-Lloyd, S. (2008), Anaphylaxis following quadrivalent human papillomavirus vaccination. Canadian Medical Association Journal. 179(6), 525-533. [Abstract]
  • Brotherton, J., Gold, M. (2008), Monitoring vaccine safety: a critical component of every immunisation program. The Medical Journal of Australia. 189(5), 243-244. [Abstract]
  • Garland, S., Brotherton, J., Skinner, S., Pitts, M., Saville, M., Mola, G., Jones, R. (2008), Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention. Vaccine. 26 Suppl 12, M80-8. [Abstract]
  • Newall, A., Brotherton, J., Quinn, H., McIntyre, P., Backhouse, J., Gilbert, L., Esser, M., Erick, J., Bryan, J., Formica, N., MacIntyre, C. (2008), Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Clinical Infectious Diseases. 46(11), 1647-1655. [Abstract]
  • Brotherton, J. (2008), How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine. 26(2), 250-256. [Abstract]
  • Skinner, R., Brotherton, J. (2008), Sexual risk assessment is not helpful for recommendations on human papillomavirus vaccination. Therapy. 5(3), 283-287.